FDA Drug Application (075416) for NAPROXEN SODIUM by ACTAVIS LABS FL INC

Back to FDA Applications sponsored by ACTAVIS LABS FL INC

Application Number075416
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 500MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPROXEN SODIUM
Active IngredientNAPROXEN SODIUM

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN SODIUM12


Back to FDA Applications sponsored by ACTAVIS LABS FL INC